Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease

Kidney International

Volumn 82, Issue 7, 2012, Pages 805-811

  Freedman, Barry I ^a   Langefeld, Carl D ^a   Turner, Jolyn ^a   Ñez, Marina ^a   High, Kevin P ^a   Spainhour, Mitzie ^a   Hicks, Pamela J ^a   Bowden, Donald W ^a   Reeves Daniel, Amber M ^a   Murea, Mariana ^a   Rocco, Michael V ^a   Divers, Jasmin ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

African American; APOL1; end stage renal disease; FSGS; kidney; screening

Indexed keywords

ALBUMIN; APOLIPOPROTEIN; APOLIPOPROTEIN L1; CREATININE; CYSTATIN C; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGE; AGED; ALBUMINURIA; APOL1 GENE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FAMILY STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RELATIVE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 84866349240     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.217     Document Type: Article

References (29)

1. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
2. Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128: 345-350.
3. Freedman BI, Kopp JB, Langefeld CD et al. The Apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010; 21: 1422-1426.
4. Reeves-Daniel AM, Depalma JA, Bleyer AJ et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011; 11: 1025-1030.
5. Bostrom MA, Freedman BI. The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol 2010; 5: 1107-1113.
6. Kopp JB, Nelson GW, Sampath K et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011; 22: 2129-2137.
7. Bostrom MA, Kao WH, Li M et al. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy. Am J Kidney Dis 2012; 59: 210-221.
8. Freedman BI, Langefeld CD, Murea M et al. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol Dial Transplant 2011; 26: 3805-3810.
9. Madhavan SM, O'Toole JF, Konieczkowski M et al. APOL1 localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol 2011; 22: 2119-2128.
10. Appel LJ, Wright Jr JT, Greene T et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010; 363: 918-929.
11. Kopp JB, Freedman BI, Winkler CA et al. APOL1 and MYH9 genetic variants are independently associated with kidney diseaes risk in African Americans. J Am Soc Nephol 2011; 22: 460A.
12. Friedman DJ, Kozlitina J, Genovese G et al. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol 2011; 22: 2098-2105.
13. Ferguson R, Grim CE, Opgenorth TJ. A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 1988; 41: 1189-1196.
14. Freedman BI, Spray BJ, Tuttle AB et al. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 1993; 21: 387-393.
15. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995; 25: 710-713.
16. Freedman BI, Wilson CH, Spray BJ et al. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997; 29: 729-732.
17. Freedman BI, Soucie JM, Stone SM et al. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 1999; 34: 254-258.
18. Bergman S, Key BO, Kirk KA et al. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. Am J Kidney Dis 1996; 27: 341-346.
19. Freedman BI, Soucie JM, McClellan WM. Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol 1997; 8: 1942-1945.
20. Freedman BI, Volkova NV, Satko SG et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol 2005; 25: 529-535.
21. Reeves-Daniel A, Bailey A, Assimos D et al. Donor-recipient relationships in African American vs. Caucasian live kidney donors. Clin Transplant 2011; 25: E487-E490.
22. Bryson CL, Ross HJ, Boyko EJ et al. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. Am J Kidney Dis 2006; 48: 720-726.
23. US Renal Data System, USRDS. 2009 Annual Data Report, Vol. 1: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2009.
24. Kanji Z, Powe CE, Wenger JB et al. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 2011; 22: 2091-2097.
25. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
26. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Int Med 2009; 150: 604-612.
27. McPeek MS, Wu X, Ober C. Best linear unbiased allele-frequency estimation in complex pedigrees. Biometrics 2004; 60: 359-367.
28. Liang K-Y, Zeger SL. Longitudinal data anlysis using generalized linear models. Biometrika 1986; 73: 13-22.
29. Box GEP, Cox DR. An analysis of tranformations. J R Stat Soc Series B 1964; 26: 211-246.